H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.
H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.
Lire l’article complet sur le site source
Bloomberg — Markets (EN)